Obese type 2 diabetes patients who had lower scores in a new system called DiaRem -- which evaluates four pre-surgery factors: age, insulin use, A1C concentration and diabetes drug type -- were more likely than those with higher scores to attain remission following gastric bypass surgery at five years, a study showed. DiaRem may provide patients and clinicians a scientific way to assess the benefits of bypass surgery and determine whether more measures are needed to boost the likelihood of remission, researchers wrote in The Lancet Diabetes & Endocrinology.

Related Summaries